ACUTAccustem Sciences Inc.
Earnings
When Accustem Sciences Inc. reports, what it reported each quarter, and how the stock took the results.
22 quarters. Mar 31, 2021 to Jun 30, 2026. USD.
Next results · Q3 2026Projected
10-Q due Nov 12 – 20
No earnings release is on file for this company, so the day is the 10-Q’s, projected from its last 8 filings.
- Quarter
- Q3 2026 · Ended Sep 30, 2026
- 10-Q window
- Nov 12 – 20
Read against Q3 2025
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
- Revenue
- —
- Net income
- -$399.90K
- Net income, change from a year earlier: Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m, Q3 2025 n/m
- EPS
- -$0.02
- EPS, change from a year earlier: Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m, Q2 2025 n/m
Latest results
- Q2 2026Aug 14, 2026, after the close
- Revenue
- $98.40K
- —
- Net income
- -$252.57K
- N/M
- EPS
- -$0.02
- N/M
- Q1 2026May 15, 2026, after the close
- Revenue
- —
- —
- Net income
- -$485.88K
- N/M
- EPS
- -$0.03
- N/M
- Q4 2025Apr 14, 2026, after the close
- Revenue
- —
- —
- Net income
- -$514.39K
- N/M
- EPS
- —
- —
- Q3 2025Nov 12, 2025, after the close
- Revenue
- —
- —
- Net income
- -$399.90K
- N/M
- EPS
- -$0.02
- N/M
All quarters
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | ||||||||||
| Q2 2026 | Jun 30, 2026 | — | Aug 14, 2026 | 45 d | 10-Q | $98.40K | — | -$0.02 | — | |
| Q1 2026 | Mar 31, 2026 | — | May 15, 2026 | 45 d | 10-Q | — | — | -$0.03 | — | |
| FY 2025 | ||||||||||
| Q4 2025derived | Dec 31, 2025 | — | Apr 14, 2026 | 104 d | 10-K | — | — | — | — | |
| Q3 2025 | Sep 30, 2025 | — | Nov 12, 2025 | 43 d | 10-Q | — | — | -$0.02 | — | |
| Q2 2025 | Jun 30, 2025 | — | Aug 14, 2025 | 45 d | 10-Q | — | — | -$0.02 | — | |
| Q1 2025 | Mar 31, 2025 | — | May 20, 2025 | 50 d | 10-Q | — | — | -$0.03 | — | |
| FY 2024 | ||||||||||
| Q4 2024derived | Dec 31, 2024 | — | Apr 3, 2025 | 93 d | 10-K | — | — | — | — | |
| Q3 2024 | Sep 30, 2024 | — | Nov 18, 2024 | 49 d | 10-Q | — | — | -$0.03 | — | |
| Q2 2024 | Jun 30, 2024 | — | Sep 16, 2024 | 78 d | 10-Q | — | — | -$0.02 | — | |
| Q1 2024 | Mar 31, 2024 | — | May 20, 2024 | 50 d | 10-Q | — | — | -$0.05 | — | |
| FY 2023 | ||||||||||
| Q4 2023derived | Dec 31, 2023 | — | Mar 22, 2024 | 82 d | 10-K | — | — | — | — | |
| Q3 2023 | Sep 30, 2023 | — | Nov 13, 2023 | 44 d | 10-Q | — | — | -$0.05 | +12.7% | |
| Q2 2023 | Jun 30, 2023 | — | Aug 14, 2023 | 45 d | 10-Q | — | — | -$0.03 | — | |
| Q1 2023 | Mar 31, 2023 | — | May 5, 2023 | 35 d | 10-Q | — | — | -$0.07 | 5.7% | |
| FY 2022 | ||||||||||
| Q4 2022derived | Dec 31, 2022 | — | Feb 15, 2023 | 46 d | 10-K | — | — | — | — | |
| Q3 2022 | Sep 30, 2022 | — | Nov 8, 2022 | 39 d | 10-Q | — | — | -$0.08 | 5.3% | |
| Q2 2022 | Jun 30, 2022 | — | Aug 12, 2022 | 43 d | 10-Q | — | — | -$0.10 | — | |
| Q1 2022 | Mar 31, 2022 | — | May 20, 2022 | 50 d | 10-Q | — | — | — | — | |
| FY 2021 | ||||||||||
| Q4 2021derived | Dec 31, 2021 | — | Apr 18, 2022 | 108 d | 10-K | — | — | — | — | |
| Q3 2021 | Sep 30, 2021 | — | — | — | — | — | — | — | — | |
| Q2 2021 | Jun 30, 2021 | — | — | — | — | — | — | — | — | |
| Q1 2021 | Mar 31, 2021 | — | — | — | — | — | — | — | — | |
Earlier years, FY 2021 to FY 2023The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Source filings
Provenance
ProvenanceData status and checks
Accustem Sciences Inc. · CIK 1850767 · Engraved from SEC EDGAR